Overview
- A Sept. 25 recording published by El País captures CEO Pablo Gallart telling managers to "reverse" wait‑time reductions, avoid high‑cost "non‑capita" care and aim for €4–5 million in EBITDA.
- Ribera Salud has sidelined Gallart from day‑to‑day management at Torrejón and launched an in‑depth audit to verify compliance with patient care standards, ethics and the law.
- The Community of Madrid has stationed a multidisciplinary team at the hospital and held urgent meetings with Ribera, stating Torrejón’s waits are at or below peer averages, activity and staffing have risen, and roughly 40 audits this year found no irregularities.
- Spain’s Health Ministry has directed the Alta Inspección to request information from Madrid and urged expanded checks across all concession hospitals, including those run by Quirón Salud.
- Reports that four managers who raised concerns through internal ethics channels were dismissed have triggered PSOE queries to the European Commission on patient rights and whistleblower protections.